Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Strategies to inhibit KIM1-mediated cell death for acute kidney injury

September 14, 2023 5:55 PM UTC

Compounds that block expression or signaling of the glycoprotein KIM1, which is upregulated during acute kidney injury, could help treat the condition.

Analyses of transcription factor prediction databases, renal protein expression in the Human Protein Atlas, gene expression changes in a mouse model of acute kidney injury, and cell-based assays identified the transcription factor YY1 as a regulator of KIM1 expression. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article